Ralf Kuriyel Repligen Corp (RGEN) insider trading activity

Ralf Kuriyel is Senior VP, R&D of REPLIGEN CORP. Currently has a direct ownership of 12,288 shares of RGEN, which is worth approximately $1.7 Million. The most recent transaction as insider was on Aug 02, 2024, when has been sold 7,148 shares (Common Stock) at a price of $159.11 per share, resulting in proceeds of $1,137,318. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.3K

0% 3M change

47.83% 12M change

Total Value Held $1.7 Million

RALF KURIYEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 02 2024	SELL Open market or private sale	$1,137,318 $159.11 p/Share	7,148 Reduced 36.78%	12,288 Common Stock
Aug 02 2024	BUY Exercise of conversion of derivative security	$15,067 $86.1 p/Share	175 Added 1.38%	12,463 Common Stock
Aug 01 2024	SELL Open market or private sale	$739,716 $165.67 p/Share	4,465 Reduced 18.82%	19,261 Common Stock
May 14 2024	SELL Payment of exercise price or tax liability	$87,223 $163.34 p/Share	534 Reduced 2.2%	23,726 Common Stock
Mar 11 2024	SELL Open market or private sale	$681,348 $193.73 p/Share	3,517 Reduced 12.66%	24,260 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	$109,433 $86.1 p/Share	1,271 Added 4.38%	27,777 Common Stock
Mar 07 2024	SELL Payment of exercise price or tax liability	$75,547 $195.72 p/Share	386 Reduced 1.44%	26,506 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$26,188 $193.99 p/Share	135 Reduced 0.5%	26,892 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$86,880 $191.79 p/Share	453 Reduced 1.65%	27,027 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	404 Added 1.45%	27,480 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	3,520 Added 11.5%	27,076 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$109,361 $154.03 p/Share	710 Reduced 2.93%	23,556 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$234,436 $188.0 p/Share	1,247 Reduced 4.89%	24,266 Common Stock
Mar 03 2023	BUY Grant, award, or other acquisition	-	3,591 Added 12.34%	25,513 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	3,468 Added 13.66%	21,922 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$62,034 $173.28 p/Share	358 Reduced 1.9%	18,454 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	$79,435 $173.44 p/Share	458 Reduced 2.38%	18,812 Common Stock
Aug 11 2022	SELL Open market or private sale	$1,232,603 $254.67 p/Share	4,840 Reduced 20.07%	19,270 Common Stock
Aug 11 2022	BUY Exercise of conversion of derivative security	$238,240 $59.56 p/Share	4,000 Added 14.23%	24,110 Common Stock
May 13 2022	SELL Payment of exercise price or tax liability	$107,085 $150.4 p/Share	712 Reduced 3.42%	20,110 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$404,612 $196.7 p/Share	2,057 Reduced 8.99%	20,822 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	4,234 Added 15.89%	22,406 Common Stock
Feb 27 2022	SELL Payment of exercise price or tax liability	$93,826 $196.7 p/Share	477 Reduced 2.49%	18,645 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$35,571 $189.21 p/Share	188 Reduced 0.97%	19,122 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	2,126 Added 9.92%	19,310 Common Stock

Ralf Kuriyel

Senior VP, R&D

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Value

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN

Account